Interleukin-1

DBCAT003913Pharmacologic class

A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA... A DrugBank category of 1 drug.

Also known as: Epidermal Cell Derived Thymocyte Activating Factor · Epidermal Cell Derived Thymocyte-Activating Factor · IL-1 · Interleukin 1 · Interleukin I
Drugs: Interleukin-1 alpha, human recombinant

What you can answer from here — as of June 18, 2018

1DrugEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

1Marketed productAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Interleukin-1 share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account